Cargando…

Metabolic effects of glucagon in humans

Diabetes is a common metabolic disorder that involves glucose, amino acids, and fatty acids. Either insulin deficiency or insulin resistance may cause diabetes. Insulin deficiency causes type 1 diabetes and diabetes associated with total pancreatectomy. Glucagon produces insulin resistance. Glucagon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adeva-Andany, María M., Funcasta-Calderón, Raquel, Fernández-Fernández, Carlos, Castro-Quintela, Elvira, Carneiro-Freire, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312800/ https://www.ncbi.nlm.nih.gov/pubmed/30619718 http://dx.doi.org/10.1016/j.jcte.2018.12.005

Ejemplares similares

The metabolic effects of APOL1 in humans
por: Adeva-Andany, María M., et al.
Publicado: (2023)

Insulin resistance is associated with subclinical vascular disease in humans
por: Adeva-Andany, María M, et al.
Publicado: (2019)

Sodium Bicarbonate Therapy in Patients with Metabolic Acidosis
por: Adeva-Andany, María M., et al.
Publicado: (2014)

Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease
por: Adeva-Andany, María M, et al.
Publicado: (2022)

Glycogen metabolism in humans()()
por: Adeva-Andany, María M., et al.
Publicado: (2016)

Liver glucose metabolism in humans
por: Adeva-Andany, María M., et al.
Publicado: (2016)

Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
por: Adeva-Andany, María M., et al.
Publicado: (2021)

The Importance of the Ionic Product for Water to Understand the Physiology of the Acid-Base Balance in Humans
por: Adeva-Andany, María M., et al.
Publicado: (2014)

LHCb Results and Perspectives
por: Adeva Andany, Bernardo
Publicado: (2018)

LHCb results and perspectives
por: Adeva Andany, Bernardo
Publicado: (2019)

Charged Lepton Flavour Violation/Lepton Number Violation searches at LHCb
por: Adeva Andany, Bernardo
Publicado: (2017)

Flavour Physics at LHCb
por: Adeva Andany, Bernardo
Publicado: (2015)

LHCb- Observation of $J/\psi p$ resonances consitent with pentaquark staes in $\Lambda^0_b \to J/\psi K^-p$ decays
por: Adeva Andany, Bernardo
Publicado: (2015)

Observation of pentaquark resonances in Λb→J/ψKp decays
por: Adeva Andany, Bernardo
Publicado: (2015)

Overview of LHCb results
por: Adeva Andany, Bernardo
Publicado: (2016)

Recent results in B physics and on multiquark states from LHCb
por: Adeva Andany, Bernardo
Publicado: (2016)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

Scientific Evidence Supporting the Beneficial Effects of Isoflavones on Human Health
por: Gómez-Zorita, Saioa, et al.
Publicado: (2020)

The Metabolic Effects of Pancreatic Hyperglycemic-Glycogenolytic Factor (Glucagon)
por: Cardillo, Leo R., et al.
Publicado: (1955)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Regulation of amino acid metabolism and α‐cell proliferation by glucagon
por: Hayashi, Yoshitaka, et al.
Publicado: (2018)

Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
por: Zhang, Li, et al.
Publicado: (2019)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

(13)C(15)N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans
por: Renuse, Santosh, et al.
Publicado: (2022)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Glucagon Regulation of Energy Expenditure
por: Kleinert, Maximilian, et al.
Publicado: (2019)

Glucagon Control on Food Intake and Energy Balance
por: Al-Massadi, Omar, et al.
Publicado: (2019)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
por: Baggio, Laurie L., et al.
Publicado: (2020)

Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism
por: Kjeldsen, Sasha A S, et al.
Publicado: (2021)

Glucagon-like peptide 1 and Glucagon-like peptide 2 in relation to osteoporosis in non-diabetic postmenopausal women
por: Montes Castillo, María Cristina, et al.
Publicado: (2019)

Direct cardiovascular effects of glucagon like peptide-1
por: Sheikh, Asfandyar
Publicado: (2013)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

New uses and formulations of glucagon for hypoglycaemia
por: Beato-Víbora, Pilar I, et al.
Publicado: (2019)

Methods and Guidelines for Measurement of Glucagon in Plasma
por: Holst, Jens J., et al.
Publicado: (2019)

Glucagon and Its Receptors in the Mammalian Heart
por: Neumann, Joachim, et al.
Publicado: (2023)

Increased biogenesis of glucagon-containing secretory granules and glucagon secretion in BIG3-knockout mice
por: Li, Hongyu, et al.
Publicado: (2015)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

What's new for antiretroviral treatment in women with HIV
por: Andany, Nisha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lduff3beu60paf176663bf404u